Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) on July 9 announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts. Ultragenyx is selling 1,311,277 shares of its common stock in this offering, and certain selling stockholders are selling 706,072 shares of common stock in this offering. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) … Continue reading Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Most Volatile NYSE Stocks: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Elizabeth Arden, Inc. (NASDAQ:RDEN), Arotech Corporation (NASDAQ:ARTX), Canadian Solar Inc. (NASDAQ:CSIQ)

Idera Pharmaceuticals Inc (NASDAQ:IDRA)’s shares decreased 6.03% to $2.65. The company on May 13 reported its financial and operational results for the quarter ended March 31, 2014. Net loss applicable to common stockholders for the three months ended March 31, 2014 was $9.1 million, or $0.12 per diluted share, compared to a net loss applicable to common stockholders of $4.1 million, or $0.15 per diluted … Continue reading Most Volatile NYSE Stocks: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Elizabeth Arden, Inc. (NASDAQ:RDEN), Arotech Corporation (NASDAQ:ARTX), Canadian Solar Inc. (NASDAQ:CSIQ)

Micro-cap Losers: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Travelzoo Inc. (NASDAQ:TZOO), Homex Development (NYSE:HXM), RadioShack Corporation (NYSE:RSH)

Idera Pharmaceuticals Inc (NASDAQ:IDRA) recently presented its new pre- clinical data that demonstrates the ability of the TLR or Toll-like receptor antagonist, IMO-8400, for inhibiting survival and the proliferation of the B-cell lymphoma cells that harbor the oncogenic MYD88- L265P genetic mutation. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock performance was -5.78% in last session and finished the day at $2.77. Traded volume was 3.02million shares in … Continue reading Micro-cap Losers: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Travelzoo Inc. (NASDAQ:TZOO), Homex Development (NYSE:HXM), RadioShack Corporation (NYSE:RSH)

NASDAQ Losers: Gogo Inc (NASDAQ:GOGO), Galena Biopharma Inc (NASDAQ:GALE), Idera Pharmaceuticals (NASDAQ:IDRA), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Gogo Inc (NASDAQ:GOGO) was the recipient of a large growth in short interest in January. As of March 31st, there was short interest totalling 10,866,166 shares, a growth of 22.4% from the March 14th total of 8,875,654 shares. Gogo Inc (NASDAQ:GOGO) stock performance was -7.70% in last session and finished the day at $16.79. Traded volume was 5.92million shares in the last session and the average … Continue reading NASDAQ Losers: Gogo Inc (NASDAQ:GOGO), Galena Biopharma Inc (NASDAQ:GALE), Idera Pharmaceuticals (NASDAQ:IDRA), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)

Citron exposes explosive findings behind the true components of Questcor Pharmaceuticals Inc (NASDAQ:QCOR) flagship drug HP Acthar Gel. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) stock performance was -9.96% in last session and finished the day at $60.75. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 2.86 million shares. The beta of the stock remained 0.95. Questcor Pharmaceuticals Inc. … Continue reading Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)